Clinical trial
Risk of Guillain-Barré Syndrome Following Meningococcal Conjugate (MCV4) Vaccination
NCT00575653 is registered in ClinicalTrials.gov with Harvard Pilgrim Health Care as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk of Guillain-Barré Syndrome Following Meningococcal Conjugate (MCV4) Vaccination
- Lead sponsor
- Harvard Pilgrim Health Care
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- December 31, 2010
- Enrollment
- Not reported
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.